305 related articles for article (PubMed ID: 33160384)
1. Molecular characterization of breast cancer: a potential novel immune-related lncRNAs signature.
Lai J; Chen B; Zhang G; Li X; Mok H; Liao N
J Transl Med; 2020 Nov; 18(1):416. PubMed ID: 33160384
[TBL] [Abstract][Full Text] [Related]
2. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
3. Construction and validation of immune-related LncRNAs classifier to predict prognosis and immunotherapy response in laryngeal squamous cell carcinoma.
Wang X; Pan Y; Ou Y; Duan T; Zou Y; Zhou X
World J Surg Oncol; 2022 May; 20(1):164. PubMed ID: 35606755
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA-based signatures to improve prognostic prediction of breast cancer.
Zhang Y; Wang Y; Tian G; Jiang T
Medicine (Baltimore); 2020 Oct; 99(40):e22203. PubMed ID: 33019395
[TBL] [Abstract][Full Text] [Related]
5. A prognostic index based on a fourteen long non-coding RNA signature to predict the recurrence-free survival for muscle-invasive bladder cancer patients.
Zhang X; Zhang M; Zhang X; Zhu X; Wang J
BMC Med Inform Decis Mak; 2020 Jul; 20(Suppl 3):136. PubMed ID: 32646427
[TBL] [Abstract][Full Text] [Related]
6. Identification and verification of an immune-related lncRNA signature for predicting the prognosis of patients with bladder cancer.
Wang J; Shen C; Dong D; Zhong X; Wang Y; Yang X
Int Immunopharmacol; 2021 Jan; 90():107146. PubMed ID: 33189610
[TBL] [Abstract][Full Text] [Related]
7. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
8. Unique metastasis-associated lncRNA signature optimizes prediction of tumor relapse in lung adenocarcinoma.
Zhang X; Han J; Du L; Li X; Hao J; Wang L; Zheng G; Duan W; Xie Y; Zhao Y; Zhang X; Zou M; Wang C
Thorac Cancer; 2020 Mar; 11(3):728-737. PubMed ID: 31994347
[TBL] [Abstract][Full Text] [Related]
9. An integrated nomogram combining lncRNAs classifier and clinicopathologic factors to predict the recurrence of head and neck squamous cell carcinoma.
Cui J; Wen Q; Tan X; Piao J; Zhang Q; Wang Q; He L; Wang Y; Chen Z; Liu G
Sci Rep; 2019 Nov; 9(1):17460. PubMed ID: 31767907
[TBL] [Abstract][Full Text] [Related]
10. Metabolism-related long non-coding RNAs (lncRNAs) as potential biomarkers for predicting risk of recurrence in breast cancer patients.
Ma JY; Liu SH; Chen J; Liu Q
Bioengineered; 2021 Dec; 12(1):3726-3736. PubMed ID: 34254565
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of novel three-long noncoding RNA signatures as a diagnostic and prognostic biomarkers of human triple-negative breast cancer.
Fan CN; Ma L; Liu N
J Cell Biochem; 2019 Mar; 120(3):3185-3196. PubMed ID: 30203490
[TBL] [Abstract][Full Text] [Related]
12. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Zhao QJ; Zhang J; Xu L; Liu FF
World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
[TBL] [Abstract][Full Text] [Related]
13. An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network.
Sun M; Wu D; Zhou K; Li H; Gong X; Wei Q; Du M; Lei P; Zha J; Zhu H; Gu X; Huang D
Breast Cancer Res Treat; 2019 May; 175(1):59-75. PubMed ID: 30715658
[TBL] [Abstract][Full Text] [Related]
14. Construction of immune-related LncRNAs classifier to predict prognosis and immunotherapy response in thymic epithelial tumors.
Su Y; Ou Y; Chen Y; Ma X
Biosci Rep; 2022 May; 42(5):. PubMed ID: 35438133
[TBL] [Abstract][Full Text] [Related]
15. Identification and Function Analysis of a Five-Long Noncoding RNA Prognostic Signature for Endometrial Cancer Patients.
Tang H; Wu Z; Zhang Y; Xia T; Liu D; Cai J; Ye Q
DNA Cell Biol; 2019 Dec; 38(12):1480-1498. PubMed ID: 31539276
[TBL] [Abstract][Full Text] [Related]
16. Identification of a Multi-RNA-Type-Based Signature for Recurrence-Free Survival Prediction in Patients with Uterine Corpus Endometrial Carcinoma.
Wang P; Zeng Z; Shen X; Tian X; Ye Q
DNA Cell Biol; 2020 Apr; 39(4):615-630. PubMed ID: 32105510
[TBL] [Abstract][Full Text] [Related]
17. A Signature of Autophagy-Related Long Non-coding RNA to Predict the Prognosis of Breast Cancer.
Li X; Chen J; Yu Q; Huang H; Liu Z; Wang C; He Y; Zhang X; Li W; Li C; Zhao J; Long W
Front Genet; 2021; 12():569318. PubMed ID: 33796128
[No Abstract] [Full Text] [Related]
18. Comprehensive analysis of autophagy-related prognostic genes in breast cancer.
Lai J; Chen B; Mok H; Zhang G; Ren C; Liao N
J Cell Mol Med; 2020 Aug; 24(16):9145-9153. PubMed ID: 32618109
[TBL] [Abstract][Full Text] [Related]
19. A Novel YTHDF3-Based Model to Predict Prognosis and Therapeutic Response in Breast Cancer.
Liu J; Zhu J; Wang X; Zhou Z; Liu H; Zhu D
Front Mol Biosci; 2022; 9():874532. PubMed ID: 35755811
[No Abstract] [Full Text] [Related]
20. A novel seven-lncRNA signature for prognosis prediction in hepatocellular carcinoma.
Yan J; Zhou C; Guo K; Li Q; Wang Z
J Cell Biochem; 2019 Jan; 120(1):213-223. PubMed ID: 30206981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
